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mania amazonensis, where host cells are devoid of Dot/Icm T4BSS effector proteins.
IMPORTANCE Coxiella burnetii, the cause of human Q fever, is the only bacterial pathogen known to replicate in a vacuole resem-
blingaphagolysosome.Theorganismmanipulateshostmacrophagestopromotethebiogenesisofavacuolarcompartmentper-
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T
he zoonotic disease agent Coxiella burnetii is a highly infec-
tious Gram-negative bacterium that causes human Q fever
(1). Aerosol-transmitted C. burnetii has a tropism for mononu-
clear phagocytes such as alveolar macrophages (2, 3). Conse-
quently, infection of cultured primary or immortalized human
monocytes/macrophages is considered the most physiologically
relevant in vitro model of C. burnetii-host cell interactions (4).
Regardless of the host cell type, C. burnetii replicates within a
membrane-bound compartment or “parasitophorous vacuole”
(PV). The C. burnetii PV is unique among vacuoles occupied by
bacterialpathogensinmaturingthroughtheendolysosomalpath-
way to ultimately acquire characteristics of a phagolysosome (4,
5). Here, the pathogen resists lysosomal hydrolases while exploit-
ing the acidic pH for metabolic activation (6).
The notion of the C. burnetii PV as a large phagolysosome is
oversimpliﬁed. Indeed, the PV also has interactions with au-
tophagicandsecretorypathwaysthatpromoteC.burnetiireplica-
tion (7–9). A mature PV ﬁlled with C. burnetii can occupy nearly
the entire host cell cytoplasm (10); thus, extensive recruitment of
membrane from other host vesicular compartments must occur
during the PV expansion phase. Cumulative evidence indicates
that C. burnetii actively mediates PV fusogencity/maintenance
(11) and other host cell processes, such as autophagy (9) and ap-
optosis (12–15), that beneﬁt pathogen growth. Inhibition of apo-
ptosis is considered a pathogenic strategy that accommodates the
slowgrowthrateofC.burnetii(15),whilefusionwithautophago-
somes may provide critical nutrients (9).
Type IVA and IVB secretion systems are critical bacterial viru-
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tosol(16).Circumstantialevidencesuggeststhatproteinstranslo-
cated by a Dot/Icm type IVB secretion system (T4BSS) are critical
for successful parasitism of macrophages by C. burnetii (17). This
model is based on the well-established role of the homologous
Dot/Icm T4BSS of Legionella pneumophila in subverting host cell
processes, such as organelle trafﬁcking, to generate a permissive
intracellular growth environment (18). The C. burnetii genome
contains 23 homologues of the 26 Legionella dot/icm genes (19),
and 62 C. burnetii Dot/Icm substrates have been identiﬁed by
using L. pneumophila as a surrogate host (12, 20–23, 28). Many
C. burnetii T4BSS substrates have features of eucaryotic proteins,
such as ankyrin repeat domains, that may functionally mimic or
antagonize the activity of host proteins (12, 21–23). However,
only AnkG has a deﬁned function in inhibiting apopotosis via
binding of the proapoptotic protein gC1qR (p32) (12).
The historic obligate intracellular nature of C. burnetii has se-
verelyimpededthedevelopmentofgenetictoolstostudytypeIVB
secretionandotherputativevirulencefactors.Fortunately,signif-
icant advances in the genetic manipulation of C. burnetii have
recentlybeenmade(24).Usinghostcell-basedpropagation,Beare
et al. (25) genetically transformed C. burnetii to chloramphenicol
resistance and mCherry red ﬂuorescent protein expression using
the mariner-based Himar1 transposon (Tn). Limitations of the
procedure include the 2 to 3 months required for the isolation of
individual transposon mutants and a technically challenging mi-
cromanipulation cloning method. These problems were solved
with the development of an axenic (host cell-free) method of
C. burnetii propagation (26, 27). Under microaerobic conditions,
a medium called acidiﬁed citrate cysteine medium 2 (ACCM-2)
supports approximately 4 logs (log10)o fC. burnetii growth in
liquidmediumandtheformationofsmall(~0.5mmindiameter)
colonies in solid medium (26). A completely axenic C. burnetii
genetic transformation system is now available that allows the
isolation of genetic transformants in about 2.5 weeks. ACCM-2
recently facilitated the development of RSF1010 ori-based shuttle
vectors that autonomously replicate in C. burnetii (22, 28). These
shuttle vectors were used to conﬁrm cytosolic delivery by C. bur-
netii of 15 Dot/Icm substrates originally identiﬁed utilizing the
heterologous L. pneumophila system (20, 22, 28).
Axenic growth also allows the isolation of C. burnetii mutants
incapable of growth in macrophages. Screening of colonies com-
posedofclonalC.burnetiiHimar1transformantsrevealedaclone
with a transposon insertion in icmD (dotP). In L. pneumophila,
IcmD is an inner membrane component of the Dot/Icm T4BSS
(29) that is required for productive host cell infection (30). In the
present study, we utilized the C. burnetii icmD::Tn mutant, along
with new systems for genetic complementation and inducible
gene expression, to probe the requirements of Dot/Icm function
in C. burnetii parasitism of human macrophages.
RESULTS
A genetic transformant of C. burnetii contains a Himar1 trans-
posoninsertioninicmD.Werecentlypublishedanaxenicproto-
col for the genetic transformation and clonal isolation of C. bur-
netii using ACCM-2 (26). An unpublished component of this
study conﬁrmed the clonality of randomly picked ACCM-2 colo-
niesbymappingthetransposoninsertionsitesofC.burnetiiNine
Mile phase II (NMII) transformed with Himar1. One clone con-
tained a transposon insertion at base 75 of the 414-bp icmD gene
(Fig. 1A). Southern blotting conﬁrmed a single transposon inser-
tion in this transformant and, as predicted by the genome se-
quence, disruption of the icmD-containing 1.62-kb HindIII frag-




ductive infection. To ascertain whether IcmD is required for the
productive infection of macrophages, one-step growth curves of
C. burnetii in THP-1 macrophages were determined and immu-
noﬂuorescence microscopy was performed. The axenic replica-
tionofNMIIandthatoftheicmD::Tnmutantwereindistinguish-
able, with both strains attaining roughly 10,000-fold increases in
genome equivalents (GE) over 6 days of incubation (Fig. 2A).
Conversely, the icmD::Tn mutant showed an only 7.9-fold in-
crease in GE at 9 days postinfection (p.i.) of THP-1 macrophages,
whereasNMIIGEincreasedbyover10,000-fold.At6daysp.i.,the
icmD::Tn mutant did not form the single large, perinuclearly lo-
calized PV typical of C. burnetii. Instead, the organism was gener-
ally lodged in tight-ﬁtting vacuoles randomly dispersed through-
FIG 1 A Himar1 transposon insertion inactivates C. burnetii icmD. (A) Schematic showing the location of a Himar1 transposon insertion in icmD. The
transposoninsertedatbase75ofthe414-bpgene.ITR,invertedterminalrepeat;H,HindIIIsite.(B)SouthernblotassayofHindIII-digestedgenomicDNAfrom
NMII and the icmD::Tn mutant hybridized with a probe speciﬁc to icmD (black bar in panel A). A 1.62-kb icmD-containing HindIII fragment was disrupted in
the icmD mutant. (C) Immunoblotting of lysates from NMII and the icmD::Tn mutant grown in ACCM-2 for 6 days. IcmD-speciﬁc antiserum detected the
14.3-kDa IcmD protein in lysates from NMII but not in those of the icmD::Tn mutant.
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mutant was not due to defective uptake by THP-1 macrophages,
asentryassaysshowedcellswithequalnumbers,i.e.,1.060.097
and 1.18  0.107, of internalized NMII and icmD::Tn mutant
bacteria, respectively.
icmD is required for cytosolic delivery of T4BSS substrates.
To conﬁrm that the deﬁciency in intracellular replication of the
icmD::Tn mutant correlated with defective cytosolic delivery of
T4BSS substrates, the CyaA translocation assay was conducted
using THP-1 macrophages infected with C. burnetii transfor-
mants expressing CyaA fusions to C. burnetii proteins CpeD and
CpeE. Both proteins have been shown to be secreted into the host
cytosol by C. burnetii using CyaA and -lactamase translocation
assays and by L. pneumophila in a DotA-dependent fashion using
the CyaA assay (22). NMII and the icmD::Tn mutant were trans-
formed with Tn7 constructs encoding CyaA alone or a CyaA fu-
sion protein under the control of the constitutive CBU1169 pro-
moter (22, 24). Tn7 was chosen over RSF1010 ori plasmids for
transformationstocircumventpotentialgenedosageeffectsasso-
ciated with plasmid copy number (~3 to 6) (24). We have shown
that,asinotherGram-negativebacteria,Tn7isinsertedasasingle
copy into the C. burnetii chromosome in an intergenic region
downstream of glmS (CBU1787), which encodes glucosamine-6-
phosphate synthetase (24, 31).
CyaA translocation assays were conducted at 2 days p.i. CpeD
andCpeEfusionproteinsweresecretedbyNMIIasindicatedbya
greater-than-100-fold increase in cyclic AMP (cAMP) levels rela-
tive to cells harboring organisms expressing CyaA alone (Fig. 3).
Conversely, secretion by the icmD::Tn mutant was not detected.
NegativesecretionwasnotduetoalackofCyaAfusionprotein,as
immunoblotting revealed the production of equal amounts of fu-
sion protein by NMII and the icmD::Tn mutant (Fig. 3). Thus,
IcmD is required for the secretion of type IVB effectors into the
host cell cytosol.
icmD is required for inhibition of apoptosis. C. burnetii pro-
teinsynthesisisrequiredtoprotectinfectedcellsagainstapoptotic
stimuli (13–15). Moreover, the C. burnetii T4BSS substrate AnkG
has deﬁned antiapoptotic activity (12). To determine if defective
type IVB secretion by the icmD::Tn mutant correlated with re-
duced protection from apoptotic cell death, THP-1 macrophages
infected for 2 days were treated for 4 h with staurosporine, an
intrinsicapoptosisinducer.Followingtreatment,cellswerescored
for the presence of nuclear cleaved poly(ADP-ribose) polymerase
(PARP), a marker of the terminal stages of apoptosis (32). Cul-
tures infected with the icmD::Tn mutant had approximately the
samepercentage(~18.5%)ofcleavedPARP-positivenucleiasun-
infected cell cultures (Fig. 4). This percentage was signiﬁcantly
higher than that in cultures infected with NMII (~3.7%), thereby
conﬁrmingthatC.burnetiitypeIVBsecretionisrequiredtoblock
apoptosis.
FIG 2 icmD is required for intracellular growth of C. burnetii. (A) One-step growth curves of NMII and the icmD::Tn mutant grown in ACCM-2 (left panel)
orTHP-1macrophages(rightpanel).GrowthwasmeasuredbyenumeratingGE.ACCM-2resultsareexpressedasthemeansofthreebiologicalreplicatesfrom
oneexperimentandarerepresentativeoftwoindependentexperiments.Errorbarsindicatethestandarddeviationsofthemeans.THP-1macrophageresultsare
expressed as the means of two biological replicates from one experiment and are representative of three independent experiments. Error bars indicate the
standarddeviationsofthemeans.(B)FluorescencemicrographsofTHP-1macrophagesinfectedfor6dayswithNMIIortheicmD::Tnmutant.C.burnetii(red)
is stained by indirect immunoﬂuorescence, and DNA (blue) is stained with DAPI. Cells contained multiplying NMII harbored within 1 or 2 large and spacious
PVs per cell, while the icmD::Tn mutant was typically observed as a single organism in dispersed, tight-ﬁtting PVs. Bar, 20 m.
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largrowthoftheicmD::Tnmutant.Alone,theicmD::Tnmutant
does not productively infect cultured macrophages. We were cu-
rious about whether growth could be rescued upon trafﬁcking of
the mutant to PVs harboring isogenic NMII, where Dot/Icm
T4BSSfunctionswouldbeprovidedintrans.THP-1macrophages
were coinfected with NMII and the icmD::Tn mutant. Immuno-
ﬂuorescence microscopy revealed PVs ﬁlled with roughly equal
numbers of each strain at 6 days p.i. (Fig. 5), suggesting that the
icmD::Tn mutant replicates when coinhabiting a vacuole gener-
ated by NMII. GE measurements conducted at 6 days p.i. con-
ﬁrmed the enhanced replication of the icmD::Tn mutant during
coinfection, with the mutant yielding 109.2 (4.7)-fold more GE
than bacteria in singly infected cells (P  0.0001).
The PV of C. burnetii and that of the protozoan parasite
L. amazonensis are superﬁcially similar in being fusogenic, mod-
eratelyacidic(pH5),anddecoratedwithlysosomalmarkers(33).
Moreover, in Chinese hamster ovary cells, L. amazonensis trafﬁcs
topreexistingC.burnetiiPVs,whereitreplicates(34).Toestablish
whethertheicmD::Tnmutantcouldtrafﬁctoandreplicatewithin
the foreign L. amazonensis PV, Vero cells infected with L. ama-
zonensis for 1 day were superinfected with the icmD::Tn mutant.
The infection was then allowed to proceed for 4 more days. This
coinfectionprotocolwasemployedbecause,inourexperiments,it
optimizedthegenerationofcoinhabitedPVs.Thesevacuoleswere
still found in less than 10% of the cells, which reﬂected the low
infection efﬁciency of L. amazonensis. Nonetheless, the icmD::Tn
mutant trafﬁcked to L. amazonensis PVs and, without exception,
replicated in this compartment, as indicated by vacuoles contain-
ing bacteria well in excess of the initial multiplicity of infection
(MOI)of1(Fig.5).EnumerationoftheicmD::TnmutantGEwas
not conducted due to the low number of coinhabited PVs within
cell cultures. Nonetheless, these data indicate the icmD::Tn mu-
tant is capable of intracellular growth in the total absence of Dot/
IcmT4BSSeffectorfunctionsifharboredinasuitableacidiccom-
partment.
Complementation of the icmD::Tn mutant requires expres-
sion of icmD, icmJ, and icmB. The C. burnetii icmD gene is the
ﬁrst gene in a predicted operon including icmJ and icmB (35).
Therefore,thetransposoninsertionintheicmD::Tnmutantcould
have a polar effect that requires complementation of the mutant
with icmD, -J, and -B. Consequently, complementation studies
were conducted using Tn7 plasmid constructs encoding icmD
(pMiniTn7-CAT::icmDP-icmD), icmDJ (pMiniTn7-CAT::icmDP-
icmDJ), and icmDJB (pMiniTn7-CAT::icmDP-icmDJB) (see Ta-
bleS1andFig.S1inthesupplementalmaterial).Theseconstructs
contain 191 bp upstream of icmD predicted to encode the endog-
enous icmD promoter.
Functional complementation, as scored by signiﬁcant GE in-
creases at 6 days p.i. and the production of large PVs harboring
FIG 3 icmD is required for cytosolic delivery of T4BSS substrates. Cytosolic
levels of cAMP following infection of THP-1 macrophages for 2 days with
NMII or the icmD::Tn mutant expressing CyaA alone or CyaA fusions to the
previously deﬁned Dot/Icm substrates CpeD and CpeE. Elevated levels of
cAMP, indicating secretion, were observed only with NMII expressing CyaA-
CpeD or -CpeE fusion protein. Results shown are from one experiment con-
ducted in duplicate and are representative of two independent experiments.
Error bars indicate the standard errors of the means. Immunoblotting signals
of CyaA and CyaA-effector fusion proteins, depicted above respective histo-
gram bars, show comparable levels of protein expression by NMII and the
icmD::Tn mutant after 6 days of growth in ACCM-2. Blots were probed with
anti-CyaA antibody.
FIG 4 icmD is required for inhibition of apoptosis. THP-1 macrophages were infected with NMII or the icmD::Tn mutant for 2 days and then treated with
staurosporine for4ht oinduce apoptosis. Uninfected cells were used as a control. (A) Detection of cleaved PARP-positive nuclei. C. burnetii (red) and cleaved
PARP (green) were labeled by indirect immunoﬂuorescence. DNA (blue) was stained with DAPI. Bar, 20 m. (B) Enumeration of cleaved, PARP-positive
(apoptotic)nuclei.Theresultsshownarefromoneexperimentconductedintriplicateandarerepresentativeoftwoindependentexperiments.Atotalof750cells
werecountedforeachcondition.Errorbarsindicatethestandarddeviationsofthemeans,andasterisksindicateastatisticallysigniﬁcantdifference(P0.0005)
from cells infected with NMII.
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transformed with Tn7::icmDJB (Fig. 6A and B). The GE yield of
the icmD::Tn mutant transformed with Tn7::icmD or Tn7::icmDJ
did not surpass that of the untransformed mutant. QuantiGene
transcript analysis of C. burnetii cultivated in ACCM-2 for 4 days
revealed negligible levels of icmD, -J, and -B transcripts in the
icmD::Tn mutant that were restored to wild-type levels following
single-copy, in cis complementation with Tn7::icmDJB (Fig. 6C).
Conversely, CBU1169, encoding the small heat shock protein
Hsp20,wasequallyexpressedbyNMII,theicmD::Tnmutant,and
the complemented icmD::Tn mutant (Fig. 6C). Immunoblotting
conﬁrmed the production of IcmD by the complemented mutant
(Fig. 6D). Collectively, our complementation results support an
operon structure for icmD, -J, and -B and conﬁrm that deﬁcient
intracellular replication of the icmD::Tn mutant is due to inacti-
vation of the Dot/Icm T4BSS.
Induction of icmDJB expression after infection rescues
growth of the icmD::Tn mutant. Successful complementation of
the icmD::Tn mutant allowed examination of the temporal re-
quirements of type IVB secretion in productive infection by
C.burnetii.Theseexperimentsrequiredthedevelopmentofasys-
tem for tightly regulated expression of the icmDJB gene cluster.
This was achieved by using a Tn7 plasmid construct containing
icmDJB under the control of an anhydrotetracycline (aTc)-
inducible promoter (pMiniTn7-CAT::TetRA-icmDJB) (see
Fig. S1 in the supplemental material). By immunoblotting, IcmD
synthesis by the icmD::Tn mutant transformed with Tn7::TetRA-
icmDJB was associated only with induced cultures (Fig. 7A).
THP-1 macrophages were infected with the icmD::Tn mutant
transformed with Tn7::TetRA-icmDJB, where aTc was added to
the culture medium at0ho r1d a yp.i. These infection conditions
were termed concurrent induction (CI) and delayed induction
(DI), respectively, and aTc was present in culture medium
throughout the infection time course. Infections were also con-
ducted without aTc (no induction, NI). At 6 days postinduction,
the CI and DI conditions yielded 50.7- and 9.1-fold increases in
transformant GE, respectively (Fig. 7B), and production of large
andspacious,LAMP-3-positivePV(Fig.7Canddatanotshown).
TheseGEincreasesweresigniﬁcantlygreaterthanthe4.2-foldGE
increase of the transformant under NI conditions, where organ-
isms were found in tight-ﬁtting, LAMP-3-positive phagosomes
(Fig. 7B and C).
The CyaA translocation assay conﬁrmed that the enhanced
replication associated with icmDJB induction correlated with a
renewedabilitytosecreteT4BSSsubstrates.TheicmD::Tnmutant
was transformed with a Tn7 construct encoding aTc-inducible
icmJBD and a CyaA fusion to CpeD expressed from the constitu-
tive CBU1169 promoter (pMiniTn7-CAT::TetRA-icmDJB-
1169P-cyaA-cpeD) (see Fig. S1 in the supplemental material). As-
sayswereconductedusinglysatesofTHP-1macrophagesinfected
for2dayswiththistransformant,withorwithoutaTcinductionat
1 day p.i. Cytosolic delivery of CyaA-CpeD by the transformed
icmD::Tn mutant occurred only under inducing conditions
(Fig. 7D).
Collectively, these data indicate that C. burnetii can initiate
signiﬁcantreplicationinhostcellsevenwhenDot/IcmT4BSShost
FIG5 CoinfectionwithNMIIorL.amazonensisrescuesintracellulargrowthoftheicmD::Tnmutant.(Top)THP-1macrophageswerecoinfectedfor6dayswith
NMII expressing mCherry red ﬂuorescent protein (24) and the icmD::Tn mutant. Both C. burnetii strains (green) and LAMP-3 (blue) were stained by indirect
immunoﬂuorescence. Confocal ﬂuorescence micrographs show coinhabited PVs with replicating NMII (yellow due to red and green overlay) and icmD::Tn
mutant bacteria (green only). Bar, 5 m. (Bottom) Vero cells were infected for 1 day with L. amazonensis promasitgotes expressing GFP and then superinfected
for 4 days with the icmD::Tn mutant. The icmD::Tn mutant (red) and LAMP-3 (blue) were stained by indirect immunoﬂuorescence. Confocal ﬂuorescence
micrographs showed coinhabited PVs with replicating L. amazonensis and icmD::Tn mutant bacteria. Bar, 5 m.
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take. Moreover, these data show that the mutant retains viability
in a nonpermissive lysosome-like vacuole.
DISCUSSION
Since the release of the Nine Mile reference strain genome se-
quence,thepredictedDot/IcmT4BSSofC.burnetiihasbeencon-
sidered essential for pathogen colonization of macrophage host
cells without supporting experimental evidence (36–38). In this
study, we present data proving that Dot/Icm function is required
for productive macrophage infection. Our icmD::Tn mutant has
no defect in axenic growth or internalization by THP-1 macro-
phages. However, intracellularly, the mutant has severe growth
defects,failstogeneratealargePV,anddoesnotprotectcellsfrom
apoptosis. These defects correlate with failed cytosolic transloca-
tionoftheDot/IcmT4BSSsubstratesCpeDandCpeE.Ourresults
areconsistentwithﬁndingsrecentlypublishedbyCareyetal.(20)
on epithelial cell interactions of an NMII mutant with icmL inac-
tivatedbyHimar1.TheicmL::Tnmutantshowsnodefectinaxenic
growth or uptake by HeLa cells but does not replicate in either
HeLa or Vero cells. Furthermore, this mutant fails to translocate
threeC.burnetiiDot/IcmT4BSSsubstrates(CBU0077,CBU0635,
and CBU1524). Thus, two independent studies have conﬁrmed
the critical importance of the Dot/Icm T4BSS in C. burnetii infec-
tion of disparate host cell types.
Inthepresentstudy,weusedanewlyestablishedC.burnetiitrans-
formation system based on Tn7 to complement the icmD::Tn mu-
tant. A Tn7insertion in the glmS-CBU1788 intergenic region has no
demonstrable effect on the axenic and in vivo growth of C. burnetii
whilehavingtheaddedbeneﬁtofallowingsingle-copy,inciscom-
plementation (24, 31). Complementation required functional ex-
pression of icmD, -J, and -B. This result is consistent with an
operon prediction by the Database of Prokaryotic Operons (35)
and the observation that transposon inactivation of icmD results
indramaticallyreducedtranscriptionofdownstreamicmJand-B.
The transcriptional arrangement of C. burnetii icmD differs from
thatofL.pneumophilawhereicmDispredictedtolieattheendof
aneight-geneoperonincludinglphAandicmMLKEGCD(30,35).
FIG 6 Intracellular growth of the icmD::Tn mutant requires the expression of icmD, icmJ, and icmB. (A) THP-1 macrophages infected for 6 days with the
icmD::TnmutanttransformedwithaTn7constructcontainingicmD,icmDJ,oricmDJBunderthecontrolofanativeC.burnetiipromoter.C.burnetii(red)was
stained by indirect immunoﬂuorescence, and DNA (blue) was stained with DAPI. Fluorescence micrographs show large PVs harboring replicating C. burnetii




(RLU). (D) Immunoblotting of lysates of C. burnetii grown in ACCM-2 for 6 days showing production of IcmD by the complemented mutant and NMII. The
experiments depicted in panels B and C were performed in triplicate, and error bars indicate the standard errors of the means.
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positive phagosome that does not expand to form the large and
spacious PV that supports robust C. burnetii replication (5, 10).
However,at6daysp.i.,weconsistentlyobservedicmD::Tnmutant
GE increases of approximately 5-fold that appear to result from
bacterial division within the ﬁrst few days of infection. We specu-
latethatthemutantiscapableofafewroundsofreplicationinthe
acidicbutnutritionallydeﬁcientphagolysosome,withreplication
ceasing after the depletion of endogenous and/or exogenous nu-
trientsources.RelativetotheuninducedicmD::Tnmutant,induc-
tion of icmDJB expression with aTc at 1 day p.i. results in a signif-
icant increase in GE, production of a typical PV, and a renewed
ability to secrete Dot/Icm T4BSS substrates. However, the GE
yields are signiﬁcantly less than that of the icmD::Tn mutant in-
duced at 0 h p.i., suggesting that the mutant loses some viability
over time. This behavior may reﬂect the acid-activated metabo-
lism of C. burnetii where loss of adenylate energy charge and in-
fectivity is observed when organisms are incubated in an acidic
buffer deﬁcient in oxidizable energy sources (6, 39). Conse-
quently, the icmD::Tn mutant may gradually lose viability while
maintaining a detectable genome because the nutrient pool is in-
sufﬁcient to maintain ATP levels. The persistence of viable-but-
nonreplicating C. burnetii in a phagolysosome was previously ob-
served in NMII-infected Vero cells treated with chloramphenicol
(11). The lower GE yield of the icmD::Tn mutant induced at 0 h
p.i.relativetoNMIImayalsosuggestsuboptimalaTcinductionof
the icmDJB operon.
The icmD::Tn mutant is capable of intracellular replication if
sequesteredinaPVgeneratedbyisogenicNMII.AdotAmutantof
L. pneumophila behaves similarly in macrophages, with a strict
requirement for synchronous coinfection with wild-type L. pneu-
mophila (40). A more intriguing behavior is replication of the
icmD::Tnmutantinthephagolysosome-likePVofL.amazonensis,
a situation where there is a complete absence of Dot/Icm T4BSS-
modulating functions. To support the growth of the mutant, the
biochemical properties of the Leishmania vacuole must closely
mimicthoseoftheC.burnetiiPVorgrowth-permissiveACCM-2.
In axenic medium, amino acids are preferred carbon and energy
sources of C. burnetii and growth declines precipitously when the
oxygen level surpasses 7.5% (27). Thus, and as suggested for the
C. burnetii PV (41), the L. amazonensis-containing vacuole, in
addition to the low pH required for C. burnetii metabolic activa-
tion, likely has ample supplies of amino acids and a low oxygen
content. Indeed, due to multiple amino acid auxotrophies, Leish-
maniaspp.appearspeciﬁcallyadaptedtogrowthinahexose-poor
but amino acid-rich modiﬁed phagolysosome of macrophages
(42). As invoked for the C. burnetii PV (9), fusion between the
L. amazonensis PV and autophagosomes is predicted to provide
important nutrients, including amino acids (8, 43).
There are striking differences between C. burnetii and L. pneu-
mophila in their temporal requirements for Dot/Icm function, a
distinction that reﬂects their unique intracellular replication
niches. To promote the development of an endoplasmic
reticulum-derived vacuole that supports replication, L. pneumo-
phila must express DotA prior to infection (44). Failure to do so
results in rapid fusion (within 15 min) of the nascent phagosome
with lysosomes and a lack of pathogen replication. These fates are
observed for most L. pneumophila dot/icm null mutants (44, 45).
Induction of DotA expression during bacterial uptake does not
rescue pathogen replication. Conversely, both NMII and the icm-
FIG 7 Induction of icmDJB expression after infection rescues the growth of
the icmD::Tn mutant. (A) aTc-inducible expression of icmD. The icmD::Tn
mutant transformed with a Tn7 construct containing aTc-inducible icmDJB
was cultivated in ACCM-2 for 3 days and then induced with aTc for 1 day.
Immunoblotting showed aTc-induced synthesis of IcmD. (B and C) aTc in-
ductionoficmDJBconcurrentwithorafterinfectionresultsinPVproduction
and signiﬁcant replication by the icmD::Tn mutant at 6 days postinduction.
THP-1 macrophages were infected with the icmD::Tn mutant transformed
with Tn7::TetRA-icmDJB, where aTc was added to the culture medium at 0 h
(CI) or 1 day (DI) p.i. Transformant infections were also conducted without
aTc (NI) and with NMII. (B) One asterisk (P  0.05) and three (P  0.0005)
asterisksindicatesigniﬁcantdifferencesinGE.Theexperimentwasperformed
three times in duplicate, and error bars indicate the standard deviations of the
means. (C) The icmD::Tn mutant grown under CI, but not NI, conditions
forms typical large, LAMP-3-positive PVs at 6 days p.i. C. burnetii and
LAMP-3 were stained by indirect immunoﬂuorescence and appear red and
green, respectively, in the merged image. Bar, 10 m. (D) Induced expression
of icmDJB restores T4BSS function by the icmD::Tn mutant. THP-1 macro-
phages were infected with the icmD::Tn mutant transformed with a Tn7 con-
struct encoding aTc-inducible icmJBD and a CyaA fusion to CpeD expressed
from the constitutive CBU1169 promoter. C. burnetii expressing CyaA alone
was used as a control. For induction of icmDJB expression, aTc was added at
1 day p.i. CyaA assays were conducted at 2 days p.i. Elevated levels of cAMP,
indicating secretion, were observed only with the complemented mutant ex-
pressing CyaA-CpeD under inducing conditions. The results shown are from
oneexperimentconductedinduplicateandarerepresentativeoftwoindepen-
dent experiments. Error bars indicate the standard errors of the means.
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somalpathway.TheicmD::Tnmutantretainsviabilityinanonfu-
sogenic phagolysosome and can therefore deploy T4BSS effectors
that promote PV development and pathogen growth at 1 day p.i.
The Dot/Icm system also participates in the uptake of L. pneumo-
phila, with wild-type bacteria phagocytosed 10 to 20 times more
efﬁciently by human macrophages than dot/icm mutants (46).
Conversely, NMII and the icmD::Tn mutant are equally internal-
ized, a result consistent with a previous report showing similar
rates of uptake of viable and inactivated C. burnetii by murine
L929 cells (47). Because C. burnetii is metabolically quiescent at
neutralpH(6),secretionofeffectorsthatinduceuptakewouldnot
be expected.
In summary, this study conﬁrms that successful macrophage
parasitismbyC.burnetiirequiressubversionofhostcellfunctions
by a repertoire of secreted Dot/Icm effector proteins. The genera-
tionofC.burnetiidot/icmmutantsallowscarefuldissectionofthe
speciﬁc cellular processes mediated by type IVB secretion, such as
apoptotic signaling and PV biogenesis. This work also illustrates
the growing amenability of C. burnetii to genetic manipulation.
MATERIALS AND METHODS
C. burnetii, L. amazonensis, Escherichia coli, and mammalian cells.
C. burnetii NMII (clone 4, RSA439) was used in this study. NMII was
axenically cultivated in ACCM-2 as previously described (26). L. ama-
zonensis IFLA/BR/67PH8/GFP was cultured as described by Wilson et al.
(48).E.colistrainsTOP10,PIR1,andBL21-AI(Invitrogen,Carlsbad,CA)
wereusedforrecombinantDNAprocedures.THP-1cells,ahumanacute
monocytic leukemia cell line (TIB-202; ATCC), and African green mon-
key kidney (Vero) cells (CCL-81; ATCC) were maintained in RPMI 1640
medium (Invitrogen) containing 10% fetal calf serum (Invitrogen) at
37°C and 5% CO2.
Cell culture infection and aTc induction. With the exception of
C. burnetii-L. amazonensis coinfections, all experiments utilized phorbol
12-myristate 13-acetate (PMA)-differentiated THP-1 cells, which accu-
rately mimic the properties of human primary macrophages (49). To
induce differentiation into macrophage-like cells, THP-1 were cells
treated with 200 nM PMA (EMD Biosciences, San Diego, CA) for 2 days.
Cells were washed twice with phosphate-buffered saline (PBS; 1 mM
KH2PO4, 155 mM NaCl, 3 mM Na2HPO4, pH 7.4) to remove PMA prior
toinfection.Forentryassays,cellswereincubatedforanadditional3days
in fresh RPMI medium following PMA treatment. This procedure in-
duces a ﬂattened cell morphology (49) that assists in the microscopic
enumeration of internalized C. burnetii bacteria. Coinfection and growth
assays used cells infected at an MOI of 1; cleaved PARP assays used cells
infected at an MOI of 25; and CyaA, QuantiGene, immunoblotting, and
entryassaysusedcellsinfectedatanMOIof200.L.amazonensisinfection
of Vero cells was conducted with stationary-phase promastigotes at an
MOI of 50. With the exception of apoptosis assays, all inocula were re-
moved after a 2-h incubation, cells were washed twice, and then fresh
medium was added to infected cell cultures. This time point was consid-
ered 0 h p.i. With the exception of entry assays, all experiments used
24-well tissue culture plates. For entry assays, ibiTreat tissue culture-
treated channeled -Slides VI0.4 (ibidi, LLC, Verona, WI) were em-
ployed. Evaluation of C. burnetii replication in ACCM-2 or THP-1 mac-
rophages was conducted by quantitative PCR (Q-PCR) of GE using a
primer-probe set speciﬁc to thedotA gene as previously described (5, 27).
Replication of mutant C. burnetii during coinfection with wild-type bac-
teria was speciﬁcally quantiﬁed by Q-PCR using a primer-probe set spe-
ciﬁc to the kanamycin resistance gene (nptII). Where indicated, aTc
(Sigma-Aldrich,StLouis,MO)wasaddedtoC.burnetiiACCM-2cultures
and infected THP-1 macrophage cultures at ﬁnal concentrations of 200
and 400 ng/ml, respectively, for induction of C. burnetii transformant
gene expression. Where indicated, staurosporine (EMD Biosciences) was
added to cell cultures at a ﬁnal concentration of 500 nM to induce apo-
ptosis.
Plasmid construction. The plasmids used in this study are listed in
TableS1inthesupplementalmaterial.Detailsofplasmidconstructionare
given in Table S2 in the supplemental material. DNA sequences were
ampliﬁed by PCR using Accuprime pfx polymerase (Invitrogen) and
gene-speciﬁc primers (Integrated DNA Technologies, Coralville, IA).
Transformation with Himar1 and Tn7. C. burnetii cultured in
ACCM-2 was transformed by electroporation as previously described
(26). For transformation with Himar1, C. burnetii was coelectroporated
with two suicide plasmids that individually code for the Himar1 trans-
poson (pITR-Kan) and the Himar1 transposase (pUC19::1169P-
Himar1C9)(seeFig.S2inthesupplementalmaterial).Fortransformation
withminiTn7,C.burnetiiwascoelectroporatedwithtwosuicideplasmids
that individually code for the Tn7 transposase (pTnS2::1169P-tnsABCD)
and modiﬁed Tn7 (derivatives of pMiniTn7T-CAT) (24). Maps of the
pMiniTn7T-CATconstructsusedinthisstudyareshowninFig.S1inthe
supplemental material. The genomic locations of Himar1 insertions were
determined using a modiﬁed version of a semirandom two-step PCR
protocol described by Chun et al. (50). The Tn-speciﬁc primers used in
the ﬁrst- and second-round PCR ampliﬁcations were ColE1-3=out (5= A
AGGGAGAAAGGCGGACAGG3=)andColE1-3=out-nested(5=CGCCT
GGTATCTTTATAGTCCTGTC 3=), respectively. All of the C. burnetii
transformants used in this study were cloned by colony picking.
PV and cleaved PARP staining. Methanol ﬁxation and staining pro-
cedures for indirect immunoﬂuorescence assays were conducted as pre-
viously described (11). Guinea pig anti-C. burnetii serum, rabbit anti-
cleaved PARP serum (Cell Signaling Technology, Danvers, MA), and a
mouse monoclonal antibody directed against LAMP-3 (CD63) (clone
H5C6; BD Biosciences) were used as primary antibodies. Alexa Fluor 488
and 594 IgG (Invitrogen) were used as secondary antibodies. Coverslips
were mounted using ProLong Gold containing 4’,6-diamidino-2-
phenylindole (DAPI; Invitrogen) to visualize DNA. Epiﬂuorescence mi-
croscopyimageswereacquiredwithaTE-2000microscopeequippedwith
a CoolSNAP HQ digital camera (Roper Scientiﬁc, Tucson, AZ) or a Ti-U
microscope equipped with a DS-Qi1Mc camera (Nikon, Melville, NY).
Confocal ﬂuorescence microscopy was performed with a modiﬁed
Perkin-Elmer UltraView spinning-disc confocal system connected to a
Nikon Eclipse Ti-E inverted microscope. Confocal images (0.2-m sec-
tions)wereacquiredwitha63oilimmersionobjectiveandaPhotomet-
rics Cascade II: 512 digital camera (Princeton Instruments, Trenton, NJ)
usingMetamorphsoftware(MolecularDevices,Inc.,Downingtown,PA).
All images were processed similarly using ImageJ software (written by
W. S. Rasband at the U.S. National Institutes of Health, Bethesda, MD,
and available at http://rsb.info.nih.gov/ij/).
Entry assay. THP-1 macrophages were exposed to C. burnetii f o r2h ,
ﬁxed with 2.5% paraformaldehyde for 15 min on ice, and then washed
three times with PBS. Subsequent steps were done at room temperature.
Cells were blocked with 1% bovine serum albumin (BSA) in PBS for
15 min and then incubated with rabbit anti-C. burnetii serum for 15 min.
Cellswerewashed,permeabilizedwith0.1%TritonX-100in1%BSA-PBS
for15min,andthenincubatedwithguineapiganti-C.burnetiiserumfor
15 min. Cells were washed and then incubated with anti-rabbit Alexa
Fluor 594 and anti-guinea pig Alexa Fluor 488 for 15 min. Cells were
mounted in ProLong gold containing DAPI. Intracellular bacteria (green
only) were enumerated by epiﬂuorescence microscopy. The experiment
was conducted three times in triplicate, and 100 host cells were counted
per replicate.
QuantiGene transcript analysis. mRNA quantiﬁcation was per-
formed using the QuantiGene reagent system v.2.0 (Panomics, Santa
Clara, CA) as previously described (22) and custom designed probes spe-
ciﬁc to icmD, icmJ, icmB, and CBU1169 (22). RNA was extracted from
C. burnetii after 4 days of growth in ACCM-2.
IcmD antiserum production. The C. burnetii icmD gene was cloned
without its predicted 5= N-terminal signal anchor sequence-encoding re-
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generate pEXP1::icmD-SP (see Table S2 in the supplemental material).
E. coli BL21/pEXP1::icmD-SP was induced for 4 h with 0.2% arabinose
and6His-IcmD-SPpuriﬁedbyNi2chromatographyusingaHis-Bind
buffer kit (EMD Biosciences) in the presence of 6 M urea. Urea was re-
moved using an Amicon Ultra centrifugal ﬁlter (3-kDa cutoff; Millipore
Corp., Billerica, MA). Puriﬁed 6His-IcmD-SP (250 g) in 25 mM Tris
buffer (pH 7.2) with 0.05% Triton X-100 was mixed with the Sigma Ad-
juvantSystemandusedtoimmunizeaNewZealandWhiterabbit.Rabbit
antiserum was generated according to protocol 2008-32.1, approved by
the Rocky Mountain Laboratories Animal Care and Use Committee.
Immunoblotting. C. burnetii expression of CyaA fusion proteins or
IcmDwasassessedbysodiumdodecylsulfate-polyacrylamidegelelectro-
phoresis and immunoblotting. Membranes were incubated with rabbit
anti-IcmDpolyclonalantibodyoramousemonoclonalantibodydirected
against CyaA (clone 3D1; Santa Cruz Biotechnology, Santa Cruz, CA).
Reacting proteins were detected using anti-rabbit (IcmD) or anti-mouse
(CyaA) IgG secondary antibodies conjugated to horseradish peroxidase
(Pierce, Rockford, IL) and chemiluminescence using ECL Pico reagent
(Pierce).
CyaAtranslocationassay.CyaAtranslocationassayswereperformed
as previously described, using the cAMP enzyme immunoassay (GE
Healthcare, Piscataway, NJ) (23).
Statistical analysis. Statistical analyses were performed using the un-
paired Student t test and Prism software (GraphPad Software, Inc., La
Jolla, CA).
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